Top news from MedWatch this week
Monday
Pharma lobby wielded ”inordinate amount of influence” over EU during pandemic
Two researchers praised Novo Nordisk’s obesity drug but didn’t disclose payments
Novo Nordisk denies sponsoring 60 Minutes segment
Pharmacosmos wins Chinese reimbursement deal
Tuesday
Eli Lilly to support production of diabetes drugs with USD 450m investment
Moderna’s chief medical officer on 3-in-1 vaccine: ”Great news for global public health”
Pharmacosmos to invest in Chinese organization following reimbursement win
Wednesday
FDA approves ALK’s house dust mite tablet for teens
FDA vaccine director flagged concerns over ”hyper-accelerated” review of Pfizer’s Covid-19 vaccine
Thursday
GN’s veteran chairman to retire
Per Wold-Olsen’s retirement is ”a great loss for GN”
US medtech group expands production in Denmark
Friday
CHMP recommends expanded approval of Dupixent
Proposed GN board member has ties to William Demant Invest CEO – GN dismisses connection
.jpg&w=384&q=75)
